Abstract submission topics

 

All topics related to screening, diagnosis and management of fetomaternal pregnancy conditions including stillbirth, preterm birth, gestational hypertension/pre-eclampsia, (pre) gestational diabetes, etc., including AI-based prediction, and excluding infection.

 

All topics related to screening and intervening for chromosomal and genetic diseases, including serum (cfDNA), screening with quantitative ultrasound, multiomics (genomics, transcriptomics, proteomics, etc.), and gene therapy.

 

All topics related to evaluation of normal brain/CNS development as well as screening, diagnosis and management of brain/CNS anomalies during pregnancy and postpartum.

 

All topics related to evaluation of normal heart development as well as screening and diagnosis of CHD, and assessment of cardiac function.

 

All topics related to screening, diagnosis and management of normal and abnormal fetal development and anatomy (other than brain and heart) and including multi-organ syndromes that lack a clear genetic diagnosis.

 

All topics related to infectious conditions during pregnancy (such as COVID-19, CMV, etc), maternal complications that can affect the fetus and peripartum/post-partum maternal conditions. 

 

All topics related to evaluation of normal or abnormal growth as well as management of growth-related problems.

 

All topics related to management of multiple pregnancies, excluding fetal interventions.

 

All topics related to normal and abnormal cord and/or placenta, including screening, diagnosis and management of the abnormally invasive placenta.

 

All topics related to ultrasound in the labour ward, including before active labour or immediately after delivery.

 

Includes all topics related to fetoscopy and other fetal interventions such as medical therapy, surgery for monochorionic pregnancies, TRAP sequences, valvuloplasty, CDH, myelomeningocele, LUTO, etc.

 

 

 

 

Includes topics related to the diagnosis and management of miscarriage, the management of pregnancy of unknown location, the diagnosis of tubal and non-tubal ectopic pregnancy. Abstracts on ultrasound guided removal of retained pregnancy tissue with or without enhanced myometrial vascularity may also be submitted. We would also be happy to see abstracts relating to the diagnosis of molar pregnancy in this category.

 

This topic relates to the use of ultrasound for the diagnosis and classification of ovarian and other adnexal pathology. In particular we are interested in the use of ultrasound to discriminate between benign and malignant ovarian masses. Work may include the use of biomarkers or other complementary imaging, but we would expect to see ultrasound data as part of the results.

 

This topic principally relates to work related to endometriosis, adenomyosis and associated pathology. However, submissions related to other causes of pelvic pain, ranging from pelvic infections, tuberculosis to chronic pain syndromes, are welcome. We also welcome abstracts on the use of ultrasound in selecting those women who will benefit from upfront (endometriosis) surgery versus those in whom a holistic (non-surgical) management is indicated.

 

We welcome abstracts on the diagnostic fertility workup, including ovarian reserve assessment, tubal patency testing, and congenital/acquired uterine anomalies. We welcome abstracts covering the use of ultrasound to conservatively manage e.g. borderline ovarian tumors, dermoid cysts, endometriomas, as well as studies on ultrasound-guided interventions to optimize fertility preservation.

 

Includes the assessment of fibroids, polyps, niches (caesarean scar defects) as well as the diagnosis of hyperplasia and endometrial carcinoma. Work on the use of contrast (e.g., saline or gel instillation sonography) is also welcome.  Abstracts on the use of ultrasound in operative hysteroscopy and laparoscopy before/during myomectomy are also welcome.

 

We would expect to see abstracts relating to the use of ultrasound to help manage women with gynecological malignancy, for example in the context of staging or managing ovarian, endometrial or cervical carcinoma, and uterine sarcoma. Work on the use of ultrasound in monitoring women during/after (surgical of medical) gynecological cancer therapy may also be considered.

 

Includes all studies relating to the use of ultrasound in urogynecology. We also welcome abstracts on the use of ultrasound in an emergency setting, including e.g., ovarian torsion, acute hematoperitoneum, or non-gynecological causes of acute pelvic pain (e.g., urolithiasis, appendicitis).

 

 

 

Within each topic we welcome abstracts on pediatric and adolescent gynecology.